Clare Hutton & Peter Colley

Hull & East Yorkshire Hospitals NHS Trust

Clare
Clare qualified in 2000 from University of Leeds with a BHSc (Hons) in Therapy Radiography. Commencing her career in London shortly returning to Hull where she had completed her clinical training and has continued to develop through her 18 year career. Clare was the lead Therapy Radiographer for IMRT, this interest led her to commence postgraduate education starting with a module specifically for IMRT; she was also awarded with a grant from her Trust to gain clinical experience in Palo Alto, San Francisco. Clare completed her PGDip in Radiotherapy & Oncology from Sheffield Hallam University in 2009. Clare has continued her postgraduate education and in 2015 graduated from the University of Leeds with an MSc in Leadership & Management in Health & Social Care which has helped her lead the radiotherapy service and recent IMRT advances in her current role as Radiotherapy Manager.

Peter
Peter is a registered Higher Specialist Scientist and the Consultant Physicist Lead for Radiotherapy Physics in Hull and has over 18 years of experience working in Radiotherapy Physics and with quality improvement systems. He has worked in various senior physics roles including the Oncology Information Systems Lead Principal Physicist, and the post of Principal Physicist Lead for Radiotherapy Treatment Planning, before moving into his current role.

dont miss

The Implementation & Development of IMRT in Hull

The seminar will explain the local implementation and development of IMRT. Demonstrating how the service gained the 24% IMRT national target and how this has been sustained. The seminar will demonstrate the excellent MDT working relationships including the changes to patient specific QA to enable patients to commence treatment within 28 days. This will include the review of equipment replacement the service has experienced since the central investment in Radiotherapy equipment.

Clare Hutton & Peter Colley will be speaking in the following theatre:

EVEN MORE SEMINARS

  • Jamie Rae: Speaking at the Oncology Convention

    Jamie Rae
    Throat Cancer Foundation

    The Throat Cancer Foundation; how we changed a government’s mind

  • James Flanagan: Speaking at the Oncology Convention

    James Flanagan
    Imperial College London

    Epigenetic biomarkers for platinum response in ovarian cancer

  • Mr Richard Steyn: Speaking at the Oncology Convention

    Mr Richard Steyn
    UK Lung Cancer Coalition / University Hospitals Birmingham NHS Foundation Trust

    Doubling Five-Year UK Lung Cancer Survival to 25% by 2025

  • Dr. Anna ME Bruynzeel: Speaking at the Oncology Convention

    Dr. Anna ME Bruynzeel
    Amsterdam UMC (formerly VUmc)

    MR Guided Adaptive Radiation Therapy; three years of clinical experience at VUmc

  • Professor Hisham Mehanna: Speaking at the Oncology Convention

    Professor Hisham Mehanna
    InHANSE, Institute of Cancer and Genomic Sciences, University of Birmingham

    Clinical trials that change patient care and the lessons learnt